Products

What will AGI do for Arbekacin sulfate?

This classification denotes an aminoglycoside antibiotic with the molecular formula C22H44N6O10.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G7395HZ992, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4))-n-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)-, sulfate (salt) but more generally known as arbekacin sulfate, which bears US NIH Compound Identifier 175989. European Medicines Agency schedules Arbekacin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12932MIG. Most nations, for tariff and trade purposes, schedule arbekacin sulfate under HS 29419000 and SITC 54139. As of Q4 2014, ARBEKACIN SULFATE remains US FDA's Preferred Term for this commodity. SMILES: C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)NC(=O)[C@H](CCN)O)N)N.OS(=O)(=O)O.